LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.30 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $572,000 | -41.5% | 6,005 | -31.4% | 0.02% | -42.9% |
Q2 2020 | $978,000 | +50.5% | 8,748 | -2.1% | 0.04% | +23.5% |
Q1 2020 | $650,000 | -30.4% | 8,932 | -0.3% | 0.03% | -19.0% |
Q4 2019 | $934,000 | -0.7% | 8,957 | -5.2% | 0.04% | -4.5% |
Q3 2019 | $941,000 | -11.9% | 9,451 | +1.0% | 0.04% | -15.4% |
Q2 2019 | $1,068,000 | +3.1% | 9,355 | +13.5% | 0.05% | 0.0% |
Q1 2019 | $1,036,000 | +74.1% | 8,245 | +88.0% | 0.05% | +52.9% |
Q4 2018 | $595,000 | -48.6% | 4,386 | +4.1% | 0.03% | -41.4% |
Q3 2018 | $1,157,000 | +27.8% | 4,215 | -3.5% | 0.06% | +20.8% |
Q2 2018 | $905,000 | +24.7% | 4,370 | -0.5% | 0.05% | +20.0% |
Q1 2018 | $726,000 | +16.2% | 4,394 | -3.7% | 0.04% | +17.6% |
Q4 2017 | $625,000 | +0.5% | 4,562 | -0.2% | 0.03% | -5.6% |
Q3 2017 | $622,000 | +13.5% | 4,570 | +1.3% | 0.04% | +9.1% |
Q2 2017 | $548,000 | +20.2% | 4,511 | +4.7% | 0.03% | +13.8% |
Q1 2017 | $456,000 | +14.3% | 4,309 | +9.7% | 0.03% | +11.5% |
Q4 2016 | $399,000 | +9.3% | 3,929 | +9.8% | 0.03% | +13.0% |
Q3 2016 | $365,000 | – | 3,579 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 1,249,766 | $58,726,504,000 | 11.17% |
BVF INC/IL | 1,108,763 | $52,101,000 | 10.82% |
GROW Partners, LLC | 132,500 | $6,226,000 | 5.58% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 936,825 | $44,021,000 | 2.73% |
First Light Asset Management, LLC | 76,366 | $3,588,000 | 2.45% |
Healthcare Value Capital, LLC | 50,000 | $2,350,000 | 2.27% |
OBERWEIS ASSET MANAGEMENT INC/ | 168,337 | $7,910,000 | 2.17% |
RK Capital | 174,283 | $8,190,000 | 1.67% |
Nichols Asset Management LLC | 133,368 | $6,267,000 | 1.30% |
ASHFORD CAPITAL MANAGEMENT INC | 108,289 | $5,089,000 | 1.09% |